Results 21 to 30 of about 1,168 (170)

Giant prolactinomas presenting as skull base tumors [PDF]

Surgical Neurology, 2002
Prolactinomas invading the skull base are rare, and could easily be confused with skull base tumors of nonpituitary origin.We report a series of 4 cases of giant prolactinomas invading the skull base and presenting with atypical symptoms. Case 1 presented with a short history of headache and nasal obstruction.
MINNITI, GIUSEPPE, JAFFRAIN REA ML, SANTORO, Antonio, ESPOSITO, Vincenzo, FERRANTE, Luigi, DELFINI, Roberto, CANTORE, Giampaolo   +6 more
core   +7 more sources

Obstructive Hydrocephalus, Fifth Nerve and Hypothalamus Involvement: Acute Presentation of a Giant Prolactinoma

Clinical Medicine Insights: Case Reports, 2012
Introduction Pituitary tumors from lactotrope cells account for about 40% of all functioning pituitary cancers. Men tend to present with a larger, more invasive and rapid growth prolactinomas than women, possibly because hypogonadism features are less ...
Naji Aljohani
exaly   +4 more sources

Therapeutic challenges of giant invasive cystic macroprolactinoma [PDF]

Endocrinology, Diabetes & Metabolism Case Reports
Giant cystic prolactinomas are extremely rare, with only four cases previously reported in the literature. Herein, we report the case of a 59-year-old male who presented with an acute decline in visual acuity.
S Mekni, H Khiari, S Bouali, R Laamouri, S Essayeh, I Rojbi, I Ben Nacef   +6 more
doaj   +2 more sources

Correlation between serum endocrine hormone levels and malignancy degree of prolactinoma and their predictive value for patient prognosis [PDF]

Scientific Reports
To investigate the correlation between serum endocrine hormone levels and the malignancy degree of prolactinomas, and analyze their predictive value for patient prognosis. A total of 100 prolactinoma patients admitted to the Affiliated Hospital of Xuzhou
Peimin Yu, Yin Ren, Bao Feng, Yi Yu, Pengjin Mei, Yufu Zhu   +5 more
doaj   +2 more sources

Giant prolactinomas in men: efficacy of cabergoline treatment [PDF]

Clinical Endocrinology, 2003
Summaryobjective The term ‘giant prolactinoma’ can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long‐lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro‐ and macroprolactinomas.
Corsello, Salvatore Maria, Ubertini, G, Altomare, M, Lovicu, Rm, Migneco, Mg, Rota, Carlo Antonio, Colosimo, Cesare   +6 more
openaire   +4 more sources

A "giant" prolactinoma [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1997
Reuter, Uwe, Mehraein, Susan, Arnold, Gerhard, Lehmann, Rüdiger   +3 more
core   +6 more sources

The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response? [PDF]

Biomedicines
Background/Objectives: Dopamine agonists (DAs) are the first-line therapy for prolactinomas; however, a subset of patients exhibits resistance or incomplete response. Methods: This retrospective study included 85 of 125 eligible consecutive patients with
Maria Komisarz-Calik, Anna Bogusławska, Aleksandra Gamrat-Żmuda, Mari Minasyan, Beata Piwońska-Solska, Jacek Kunicki, Grzegorz Zieliński, Agata Faron-Górecka, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska   +9 more
doaj   +2 more sources

Giant Prolactinoma Presenting With Facial Nerve Palsy and Hemiparesis [PDF]

Journal of the Endocrine Society, 2021
Faryal Mírzá, Joseph Lorenzo, Aleksandra Śliwińska   +2 more
exaly   +2 more sources

Dopamine Agonist Therapy Induced Fatal Pneumocephalus in Giant Prolactinoma [PDF]

JCEM Case Rep
Rohit Barnabas, Tushar Bandgar, Anurag Ranjan Lila   +2 more
exaly   +2 more sources

Correction: Giant prolactinoma with progressive cranial settling and central herniation: a case report [PDF]

Journal of Medical Case Reports
Taha Shahbazi, Soheil Abdollahi Yeganeh, Shiva Borzouei, Mahdi Arjipour   +3 more
doaj   +2 more sources